At today's FDA Panel conference on the long term use of osteoporosis drugs like Fosamax, presenter Arthur C. Santora MD, PhD, speaking for Merck, the drug manufacturer, attempted to convince the panel that limits on the duration of the drugs use were not necessary. However, Dr. Santora did admit that drug "holiday" (meaning a temporary interruption in usage) may be considered for patients who are no longer considered to have a sufficiently high fracture risk.
In the early morning session of today's FDA Panel conference on the long term use of bisphosphonates, like the drug Fosamax, the FDA's Lead Medical Officer Fatmatta Kuyateh, M.D. indicated that radiographic findings consistent with atypical femur fractures case have been associated with bisphosphonate use.
Drug companies to pay the FDA $100 million in additional fees. The upside (or is it?): 2,000 regulators get to keep their job and new drugs will continue to funnel into the market. The downside: the FDA will increase its staff and drug companies get additional face time during the drug review process. The last PDUFA reauthorization in 2007 was highly disputed when the FDA failed to monitor dangerous drugs such as Vioxx.
What constitutes proof of a conspiracy? And what does it take to demonstrate that a toxic substance actually does cause disease?
It is no secret – at least to those who are paying attention – that in the U.S. (and increasingly, around the world), rights and protections for natural human beings are being stripped away while at the same time, corporations are given more rights, more protections – and a whole lot less accountability.
In reference to the well known jury selection strategy known as the Reptile Theory, trial attorney Clay Mitchell is highlighted as a "Superstar" in relation to a recent multi-million dollar jury verdict.
Most asbestos exposure is the result of industrial use as well as construction, ship building, electronics, automotive manufacture and servicing, aviation...the list goes on and on and on.
Although asbestos continues to be a source of illness – and the litigation that results from it – there is seemingly no end to product liability.
By Levin Papantonio Attorney Daniel Nigh
I’ve spoken with a few prospective clients who have felt bad for DePuy and Johnson & Johnson. They thought that the corporations had good intentions with these recalled hips and just all of a sudden found out these hips were bad and immediately recalled them. However, that couldn’t be further from the truth. These major corporations put profit over the safety of the patients.
FDA Complaints Regarding the Recalled DePuy Hip (ASR) and All Metal on Metal Hips Continue to Mount Up
By: Levin Papantonio Attorney Daniel Nigh
Berry Meier, of the New York Times, has reported yet another installment on the defective DePuy hips and on Metal on Metal hips in general. Here is a link to the story: http://www.nytimes.com/glogin?URI=http://www.nytimes.com/2011/08/23/business/complaints-soar-on-hip-implants-as-dangers-are-studied.html&OQ=_rQ3D2Q26hp&OP=22747606Q2F!oTQ5E!Q5BdpJOddMG!GeQ51Q51!eQ60!GQ2B!Q5E9JrQ27TJJ!pdzPRYrQ27MJQ3FJdYOQ3FdQ27Q3F)rPQ3FrzPRYQ27MJQ3FYJQ3FQ5BYQ27ZTOJQ3FYOTQ3FJM9Q5BrTQ5BQ3C)MzR.
In the first case of the so-called Engle progeny to reach the Florida Supreme Court, the court has declined to review a lower court’s decision upholding $3.3 million in compensatory damages and $25 million in punitive damages for the widow of a smoker. (R.J. Reynolds Tobacco Co. v. Martin, No. SC11-483 (Fla. July 19, 2011).)
By The News Service of Florida, Herald-Tribune
In a decision with huge implications for lawsuits against tobacco companies, the Florida Supreme Court on Tuesday declined to hear R.J. Reynolds’ appeal of a $28.3 million verdict in the death of a Panhandle smoker.
Court ruling may be big help for smoker plaintiffs
Legal / Law Matters
Jose Pagliery, Daily Business Review, On Thursday December 16, 2010, 3:02 am
The oil seems disappeared in the gulf of Mexico, now argues the lawyers about how many billions of dollars BP will pay to the victims of the environmental disaster.
Pensacola attorney Brian Barr is one of only four lawyers chosen by a federal judge to oversee thousands of claims against BP, Halliburton and Transocean for damages caused by the Gulf oil spill.
[Norman, Oklahoma] – Peter Mougey, a partner in the Pensacola-based law firm Levin Papantonio was, on Friday, October 15, inducted as the president of PIABA, the national securities bar. Mougey is the chair of the firm’s securities department.
[New York, N.Y., June 25, 2010] A jury in the United States District Court for the Southern District of New York found that Merck's osteoporosis drug Fosamax was defectively designed and unreasonably dangerous. As reported in the Wall St. Journal, the jury verdict raises serious questions about the safety of Fosamax for some patients. A medication widely prescribed for loss of bone density which might lead to osteoporosis, Fosamax has been linked not only to osteonecrosis of the jaw (a rotting of the jaw bone), but also more recently to serious fractures of the femur.